Atlas Trials

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

Clinical trial NCT02406144 · COMPLETED

Trial details

NCT number
NCT02406144
Sponsor
PETHEMA Foundation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-11-01
Primary completion
2017-09-01
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.